Medical prevention of stroke, 2003

被引:10
作者
Kirshner, HS [1 ]
机构
[1] Vanderbilt Univ, Sch Med, Dept Neurol, Nashville, TN 37212 USA
关键词
ACETYLSALICYLIC-ACID; RANDOMIZED-TRIAL; ISCHEMIC-STROKE; RISK-FACTOR; STATINS; DISEASE; INTERVENTION; CONSUMPTION; PRAVASTATIN; MORTALITY;
D O I
10.1097/01.SMJ.0000063469.77850.08
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Stroke is a preventable tragedy for nearly 750,000 people each year. Primary stroke prevention measures applicable to the general public include a healthy diet containing fruits, vegetables, fish, and low fat; exercise; smoking cessation; limiting alcohol to moderate use; and perhaps avoidance of stress. Screening for hypertension, cholesterol, heart disease, and carotid artery stenosis can lead to even more effective stroke prevention in high-risk patients. Specific antihypertensive drugs such as angiotensin-converting enzyme inhibitors and angiotensin-converting enzyme receptor blockers may be especially protective against stroke. Secondary stroke prevention in patients who have already had a stroke or transient ischemic attack is even more effective in preventing more serious strokes. Measures include antihypertensive and cholesterol-lowering agents, carotid endarterectomy, anticoagulation for atrial fibrillation and other cardiac sources of embolic stroke, and antiplatelet therapy. Stroke prevention depends on the application of these well-known and widely available treatments to a large number of patients.
引用
收藏
页码:354 / 358
页数:5
相关论文
共 50 条
[1]   Antithrombotic and thrombolytic therapy for ischemic stroke [J].
Albers, CW ;
Amarenco, P ;
Easton, JD ;
Sacco, RL ;
Teal, P .
CHEST, 2001, 119 (01) :300S-320S
[2]  
[Anonymous], 1988, Br Med J (Clin Res Ed), V296, P316
[3]  
[Anonymous], 1978, N ENGL J MED
[4]  
*ANT TRIAL COLL, 1998, BMJ-BRIT MED J, V296, P320
[5]  
Antiplatelet Trialists' Collaboration, 1994, BMJ-BRIT MED J, V308, P81, DOI [10.1136/bmj.308.6943.1540, DOI 10.1136/BMJ.308.6921.81]
[6]  
Baigent C, 2002, BMJ-BRIT MED J, V324, P71, DOI 10.1136/bmj.324.7329.71
[7]   A QUANTITATIVE ASSESSMENT OF PLASMA HOMOCYSTEINE AS A RISK FACTOR FOR VASCULAR-DISEASE - PROBABLE BENEFITS OF INCREASING FOLIC-ACID INTAKES [J].
BOUSHEY, CJ ;
BERESFORD, SAA ;
OMENN, GS ;
MOTULSKY, AG .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1995, 274 (13) :1049-1057
[8]   The Greater Cincinnati Northern Kentucky Stroke Study - Preliminary first-ever and total incidence rates of stroke among blacks [J].
Broderick, J ;
Brott, T ;
Kothari, R ;
Miller, R ;
Khoury, J ;
Pancioli, A ;
Gebel, J ;
Mills, D ;
Minneci, L ;
Shukla, R .
STROKE, 1998, 29 (02) :415-421
[9]  
Callahan A, 2001, AM J CARDIOL, V88, p33J
[10]   Executive summary of the Third Report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III) [J].
Cleeman, JI ;
Grundy, SM ;
Becker, D ;
Clark, LT ;
Cooper, RS ;
Denke, MA ;
Howard, WJ ;
Hunninghake, DB ;
Illingworth, DR ;
Luepker, RV ;
McBride, P ;
McKenney, JM ;
Pasternak, RC ;
Stone, NJ ;
Van Horn, L ;
Brewer, HB ;
Ernst, ND ;
Gordon, D ;
Levy, D ;
Rifkind, B ;
Rossouw, JE ;
Savage, P ;
Haffner, SM ;
Orloff, DG ;
Proschan, MA ;
Schwartz, JS ;
Sempos, CT ;
Shero, ST ;
Murray, EZ .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2001, 285 (19) :2486-2497